Last reviewed · How we verify
Ce 3 ng/ml
Ce 3 ng/ml is a drug that works by
At a glance
| Generic name | Ce 3 ng/ml |
|---|---|
| Sponsor | Imam Abdulrahman Bin Faisal University |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
However, the exact mechanism of action is not well understood at this time.
Approved indications
Common side effects
Key clinical trials
- The Effects of Three Different Anesthetic Methods on Postoperative Agitation (NA)
- Comparison of the Effects of Total Intravenous Anaesthesia With Target-Controlled Infusion (TCI) and Inhalation Anaesthesia on Airway Complications During Extubation and in the Early Postoperative Period in Thyroidectomy Surgery (NA)
- Oxidative Stress Effects of TIVA, CIVA, and Balanced Anesthesia in VATS (NA)
- Total Intravenous Anesthesia Versus Sevoflurane Anesthesia for Endovascular Thrombectomy in Acute Ischemic Stroke (NA)
- Evaluation of the EEG Connectivity Using Predominant Dexmedetomidine as Anesthetic in Fragile Brains
- Effectiveness of Hypnosis Via Virtual Reality During Oocyte Retrieval (NA)
- Low Remifentanil Target Controlled Infusions for Cardiac Surgery (PHASE3)
- The Comparison of Changes of QTc, Tp-e Interval, and Tp-e/QT Ratio, Tp-e/QTc Ratio on the ECG During Robotic-assisted Laparoscopic Radical Prostatectomy Under Sevoflurane, Desflurane and Total Intravenous Anesthesia -Randomized Controlled Trial (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |